Literature DB >> 30125110

Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.

Gianluca Santoni1,2, Julien de Sousa3,4, Eugenio de la Mora1, José Dias2, Ludovic Jean5, Joel L Sussman6, Israel Silman7, Pierre-Yves Renard5, Richard C D Brown4, Martin Weik1, Rachid Baati3, Florian Nachon2.   

Abstract

Acetylcholinesterase (AChE), a key enzyme in the central and peripheral nervous systems, is the principal target of organophosphorus nerve agents. Quaternary oximes can regenerate AChE activity by displacing the phosphyl group of the nerve agent from the active site, but they are poorly distributed in the central nervous system. A promising reactivator based on tetrahydroacridine linked to a nonquaternary oxime is also an undesired submicromolar reversible inhibitor of AChE. X-ray structures and molecular docking indicate that structural modification of the tetrahydroacridine might decrease inhibition without affecting reactivation. The chlorinated derivative was synthesized and, in line with the prediction, displayed a 10-fold decrease in inhibition but no significant decrease in reactivation efficiency. X-ray structures with the derivative rationalize this outcome. We thus show that rational design based on structural studies permits the refinement of new-generation pyridine aldoxime reactivators that may be more effective in the treatment of nerve agent intoxication.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30125110     DOI: 10.1021/acs.jmedchem.8b00592

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase.

Authors:  Oksana Gerlits; Xiaotian Kong; Xiaolin Cheng; Troy Wymore; Donald K Blumenthal; Palmer Taylor; Zoran Radić; Andrey Kovalevsky
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

Review 2.  Resurrection and Reactivation of Acetylcholinesterase and Butyrylcholinesterase.

Authors:  Andrew J Franjesevic; Sydney B Sillart; Jeremy M Beck; Shubham Vyas; Christopher S Callam; Christopher M Hadad
Journal:  Chemistry       Date:  2019-02-13       Impact factor: 5.236

3.  A New Class of Bi- and Trifunctional Sugar Oximes as Antidotes against Organophosphorus Poisoning.

Authors:  Ophélie Da Silva; Nicolas Probst; Christophe Landry; Anne-Sophie Hanak; Pierre Warnault; Caroline Coisne; André-Guilhem Calas; Fabien Gosselet; Charlotte Courageux; Anne-Julie Gastellier; Marilène Trancart; Rachid Baati; Marie-Pierre Dehouck; Ludovic Jean; Florian Nachon; Pierre-Yves Renard; José Dias
Journal:  J Med Chem       Date:  2022-03-07       Impact factor: 7.446

4.  Dual acting oximes designed for therapeutic decontamination of reactive organophosphates via catalytic inactivation and acetylcholinesterase reactivation.

Authors:  Jayme Cannon; Shengzhuang Tang; Kelly Yang; Racquel Harrison; Seok Ki Choi
Journal:  RSC Med Chem       Date:  2021-08-04

Review 5.  Organophosphorus compounds and oximes: a critical review.

Authors:  Franz Worek; Horst Thiermann; Timo Wille
Journal:  Arch Toxicol       Date:  2020-06-06       Impact factor: 5.153

6.  Molecular modeling studies on the interactions of 7-methoxytacrine-4-pyridinealdoxime, 4-PA, 2-PAM, and obidoxime with VX-inhibited human acetylcholinesterase: a near attack conformation approach.

Authors:  Jorge Alberto Valle da Silva; Eugenie Nepovimova; Teodorico Castro Ramalho; Kamil Kuca; Tanos Celmar Costa França
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

7.  Broad-Spectrum Antidote Discovery by Untangling the Reactivation Mechanism of Nerve-Agent-Inhibited Acetylcholinesterase.

Authors:  Cecilia Lindgren; Nina Forsgren; Norman Hoster; Christine Akfur; Elisabet Artursson; Lotta Edvinsson; Richard Svensson; Franz Worek; Fredrik Ekström; Anna Linusson
Journal:  Chemistry       Date:  2022-06-07       Impact factor: 5.020

8.  Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease.

Authors:  Prayasee Baruah; Abhinandan Das; Debojit Paul; Suman Chakrabarty; Kripamoy Aguan; Sivaprasad Mitra
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-06

9.  Efficacy Assessment of an Uncharged Reactivator of NOP-Inhibited Acetylcholinesterase Based on Tetrahydroacridine Pyridine-Aldoxime Hybrid in Mouse Compared to Pralidoxime.

Authors:  André-Guilhem Calas; Anne-Sophie Hanak; Nina Jaffré; Aurélie Nervo; José Dias; Catherine Rousseau; Charlotte Courageux; Xavier Brazzolotto; Pascal Villa; Adeline Obrecht; Jean-François Goossens; Christophe Landry; Johan Hachani; Fabien Gosselet; Marie-Pierre Dehouck; Jagadeesh Yerri; Maria Kliachyna; Rachid Baati; Florian Nachon
Journal:  Biomolecules       Date:  2020-06-04

10.  Development of a CNS-permeable reactivator for nerve agent exposure: an iterative, multi-disciplinary approach.

Authors:  Brian J Bennion; Michael A Malfatti; Nicholas A Be; Heather A Enright; Saphon Hok; C Linn Cadieux; Timothy S Carpenter; Victoria Lao; Edward A Kuhn; M Windy McNerney; Felice C Lightstone; Tuan H Nguyen; Carlos A Valdez
Journal:  Sci Rep       Date:  2021-07-30       Impact factor: 4.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.